We enjoy critically analyzing the science and business that drives each company within the life sciences sector.
science always has limitations
Companies are aware that most investors lack the expertise to critically determine the limitations to the science that drives the drug development process. Such limitations are always hidden from the public.
know what you own
We would like to provide a scientific investment thesis, which critically assesses the scientific, clinical, and business aspects that drives a company’s directional purpose, and provide a dissertation that details the qualities that either make for a long-term investment, or not.
